- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02565329
Serum Lactate Trend in Liver Resection
Serum Lactate Trend in Liver Resection With Intermittent Pringle Maneuver: The "Square-Root" Shape
Study Overview
Status
Conditions
Detailed Description
During liver resection high serum lactate (sLac) concentration can be related to several clinical factors: impairment in lactate metabolism (i.e. extraction and utilization by the liver) or overproduction by splanchnic tissues; restrictive fluid regimen in order to limit the intraoperative back-flow bleeding; ischemia-reperfusion syndrome. However, the Pringle maneuver (temporary clamping of the hepatic hilum) seems having a sensible effect in inducing a significant increase in sLac levels during liver resection, particularly in the event of compromised liver function such as in cirrhosis.
Although the peak of sLac concentration may correlate with outcome, the lactate clearance (cLac) seems to be a better predictor. To date, this relationship has been mainly demonstrated in severe sepsis and shock septic. However, the effective correlation between the cumulative clamping time and cLac has not been clearly investigated. The correlation between cumulative hepatic ischemic time and sLac trend in the perioperative period after liver resection with intermittent PM was investigated.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Milan
-
Rozzano, Milan, Italy, 20089
- Department of Hepatobiliary and General Surgery, Humanitas Research Hospital, University of Milan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients scheduled for liver resection for hepatic tumors
Exclusion Criteria:
- Patients who received blood transfusion or affected by chronic renal failure were excluded
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Serum lactate concentration trend after liver resection
Time Frame: within the first 30 days after surgery
|
within the first 30 days after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Guido Guido, Guido, Humanitas Research Hospital, Humanitas University, via Manzoni 56, 20089 Milan
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LacClearance
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lactase Persistence
-
Shannaz Nadia YusharyahyaUnknownSunscreen PersistenceIndonesia
-
Bispebjerg HospitalUnknownSunscreen Persistence | Vitamin D Production in the SkinDenmark
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
Zuyderland Medisch CentrumNederlandse Obesitas KliniekRecruitingObesity, Morbid | Bariatric Surgery Candidate | Medication PersistenceNetherlands
-
University Medical Centre LjubljanaUnknownPersistence of Infection With Helicobacter PyloriSlovenia
-
AmgenTerminatedPersistence to EnbrelCanada
-
University of Colorado, DenverCenters for Disease Control and PreventionWithdrawnPersistence of Varicella ImmunityUnited States
-
yongjun wangMinistry of Science and Technology of the People´s Republic of ChinaCompletedIschemic Stroke | Medication PersistenceChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States